PURLs

Dust mite control measures don’t help asthma patients

Author and Disclosure Information

 

References

WHAT’S NEW?: Nothing is new, yet this will be “news” to many

This Cochrane review includes 5 additional trials that have been conducted since the last Cochrane review of this topic in 2004. However, the 2004 review reported the same conclusion—that interventions to reduce house dust mite exposure in asthma patients are ineffective—as did 3 other Cochrane reviews on the same topic beginning in 1998.5-8

So why are the guidelines out of step? Schmidt and Gøtzsche (one of the authors of the Cochrane review) conducted a systematic review of narrative review articles in 2005 to answer this question. They found 70 review articles, 90% of which recommended physical methods to reduce exposure to house dust mites. They discovered that although these review articles included references to support their recommendations of dust mite control measures, the reviews showed significant bias in favor of positive studies and highlighted the results of low-quality studies, including non-randomized studies that had been excluded from the Cochrane reviews.9

CAVEATS: Duration of studies not long enough?

We know that extreme measures to reduce exposure to dust mite allergen, such as relocating to a high altitude or prolonged hospitalization, can reduce asthma symptoms,10,11 but these are clearly not practical solutions for most patients with dust mite-sensitive asthma. When it comes to this Cochrane review, some might argue that many of the interventions included were not of sufficient duration and did not sufficiently reduce the level of house mite allergen to improve asthma symptoms.

However, the subgroups of trials with long treatment duration (1-2 years) and successful mite reduction (determined by different methods, including mite counts and measured antigen levels in dust samples) also failed to show a significant difference between intervention and control groups.1

Tweak the approach? Most dust mite-sensitive asthma patients are sensitive to other allergens, so perhaps multifaceted interventions that target multiple allergens would be more effective.12 But until these potential interventions are supported by stronger evidence, we should not recommend them to our patients.

CHALLENGES TO IMPLEMENTATION: Swimming against the tide is never easy

Although the evidence to date indicates that interventions to reduce home dust mite exposure are ineffective, there are hundreds of products—including mattress and pillow covers ($10-$100), ionizers ($100-$200), and air filtration systems ($500-$800)—that are being marketed to patients with asthma. In addition, patient education handouts from sources such as the American Academy of Family Physicians, the American Academy of Pediatrics, and UpToDate recommend implementing dust mite control measures to reduce dust mite allergen exposure.13-15

We need to start educating our asthma patients properly so they can spend their time, energy, and money on interventions, such as medications, that work—and not on interventions that make no difference.

Acknowledgements

The PURLs Surveillance System is supported in part by Grant Number UL1RR024999 from the National Center for Research Resources, a Clinical Translational Science Award to the University of Chicago. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources or the National Institutes of Health.

This study was selected and evaluated using FPIN’s Priority Updates from the Research Literature (PURL) Surveillance System methodology. The criteria and findings leading to the selection of this study as a PURL can be accessed at www.jfponline.com/purls.

Pages

Copyright © 2008 The Family Physicians Inquiries Network.
All rights reserved.

Online-Only Materials

AttachmentSize
PDF icon JFP05712789_methodology49.23 KB

Recommended Reading

Are inhalers with spacers better than nebulizers for children with asthma?
MDedge Family Medicine
How effective are leukotriene inhibitors for asthma in children?
MDedge Family Medicine
Is nedocromil effective in preventing asthmatic attacks in patients with asthma?
MDedge Family Medicine
What best prevents exercise-induced bronchoconstriction for a child with asthma?
MDedge Family Medicine
What is the preferred treatment for a child with mild persistent asthma?
MDedge Family Medicine
Are any alternative therapies effective in treating asthma?
MDedge Family Medicine
Help patients gain better asthma control
MDedge Family Medicine
Changes in recommended treatments for mild and moderate asthma
MDedge Family Medicine
Educational interventions improve outcomes for children with asthma
MDedge Family Medicine
High-dose zafirlukast in emergency department provides small benefit in acute asthma
MDedge Family Medicine